* apologies for the error in the title*
Tissue Therapies announces placement and fully-underwritten 1-for-15 entitlement
offer to raise approximately A$7.7 million
Capital raising overview
• Placement to raise approximately A$4.0 million.
• Fully underwritten 1-for-15 non-renounceable entitlement offer to raise approximately A$3.7 million.
• Offer price of $0.21 per new share, a 36.5% discount to the weighted average closing price for the ten
trading days to 30 January 2015.
• Morgans Corporate Limited and Baillieu Holst Ltd are the Joint Lead Managers and Underwriters to the
capital raising.
